Alyeska Investment Group
IBB icon

Alyeska Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

Alyeska Investment Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-570,000
Closed -$49.6M – 454
2016
Q1 		$49.6M Buy
+570,000
New +$51M 0.46% 74

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alyeska Investment Group's IBB Position: Q2 2016 in Review

Alyeska Investment Group sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 570,000 shares — an estimated $49.6M sold.

Alyeska Investment Group first reported a position in IBB in Q1 2016 and held it in 1 quarter. The position peaked at $49.6M in Q1 2016. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

  • Alyeska Investment Group reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 570,000 iShares Biotechnology ETF shares in Q2 2016, an estimated $49.6M.
  • Alyeska Investment Group first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 1 quarter.
  • Alyeska Investment Group's iShares Biotechnology ETF position peaked at $49.6M in Q1 2016.
  • 428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Alyeska Investment Group's 13F filing for Q2 2016, filed 15 Aug 2016.